p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.

Hepatology (Baltimore, Md.)(2023)

引用 0|浏览32
暂无评分
摘要
Attenuating hepatic p16 expression may be a therapeutic approach for improving NAFLD/NASH phenotypes.
更多
查看译文
关键词
biliary e2f1/foxo1/igf-1,liver
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要